Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils
Rajesh K. Thimmulappa, Ralph J. Fuchs, Deepti Malhotra, Catherine Scollick, Kassim Traore, Jay H. Bream, Michael A. Trush, Karen T. Liby, Michael B. Sporn, Thomas W. Kensler, Shyam Biswal
Dive into the research topics of 'Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils'. Together they form a unique fingerprint.